Table 2.
Substance | CC 50 (μg/mL) a | CC 90 (μg/mL) a | IC 50 (μg/mL) b | IC 90 (μg/mL) b | SI c | RP d |
---|---|---|---|---|---|---|
n-BuOH | 2614 ± 366 | 821 ± 115 | 7,1 ± 1,0 | 40,9 ± 5,7 | 20 | 10 |
EtOAc | 457,7 ± 9,5 | 176,1 ± 3,5 | 8,2 ± 0,2 | 89,1 ± 4,4 | 2 | 1 |
EtOAc-Pp | 324,1 ± 6,5 | 154,7 ± 3,1 | 2,5 ± 0,1 | 4,7 ± 0,3 | 33 | 16,5 |
ribavirin | 523,1 ± 42,5 | 215,4 ± 6,2 | 62,3 ± 4,4 | 112,4 ± 8,2 | 2 | nd |
a50% and 90% cytotoxic concentration.
b50% and 90% inhibitory concentration of viral replication.
cSelectivity Index = standard IC90/substance IC90.
dRelative Potency = ratio between ribavirin (reference substance) IC90 and the tested substance’s IC90.
nd – Not determined.